captured official filings
AUTOMATED SEC FILING DILIGENCE BRIEF
PUBLIC-RECORD DELIVERY
Grey Matters Health Inc.
Automatically organized from the issuer’s official SEC submissions index. This brief is the starting evidence layer for buyer, FA, legal and broker-dealer review—not a legal conclusion or safety rating.
captured official filings
captured official filings
captured official filings
WHAT THIS AUTOMATES
One evidence index instead of a manual filing hunt.
It groups recent reporting, registration/offer, ownership and governance filings, preserves the SEC source link and keeps a reusable chronology in the issuer’s record.
PROFESSIONAL DELIVERY LAYER
What teams can pay to automate next.
Cross-version text comparison, monitored alerts, change-specific diligence questions, CSV/PDF exports and a shared deal-team brief are the professional workflow built on this public evidence layer.
MACHINE-DETECTED FILING CHANGE RADAR
Public registration text delta
Comparing F-1/A filed 2022-05-09 with F-1/A filed 2022-06-03.
Tracked-term count changes
Counts are navigation signals, not conclusions. Open both official filings to determine materiality.
- shares73 → 62-11
- offering82 → 83+1
- dilution5 → 6+1
Candidate disclosure excerpts
Only sentence-level additions or removals containing tracked diligence terms are shown. These are reading cues, not materiality findings.
New in latest filing
- On June 1, 2022, the closing price of our Common Shares was US$4.23 CAD$5.35 and €4.12 respectively.
- As of June 1, 2022, the last reported sales price of our Common Shares on the OTCQB was US$4.23 per share, and on June 2, 2022 we had 1,674,868 Common Shares outstanding.
- Inc., as representative (the " Representative ") of the underwriters in this offering, Warrants (" Compensation Warrants ") each exercisable to purchase up to a total of 106,666 Common Shares (which final amount shall be equal to 5.0% of the Common Shares and/or Pre-Funded Warrants sold in this offering) assuming a public offeri
Present in earlier filing, not found in latest
- On May 5, 2022, the closing price of our Common Shares was US$4.348 CAD$5.20 and €3.685 respectively.
- As of May 5, 2022, the last reported sales price of our Common Shares on the OTCQB was US$4.348 per share, and on May 5, 2022 we had 1,674,868 Common Shares outstanding.
- We have assumed a public offering price of US$4.348 per Unit, which represents the last reported sale price of our Common Shares as reported on the OTCQB on May 5, 2022.
Method: readable plain text is extracted from two official SEC HTML filings, then compared at sentence and tracked-term level. Formatting, exhibit differences and boilerplate may create false positives. This radar is not legal advice, a disclosure completeness opinion or a transaction recommendation.
DOWNLOAD EDITION
Save a project-ready issuer record.
US$29 one time. No subscription and no account. You receive the current printable Evidence Snapshot in this browser immediately after verified payment.
- Source-linked filing chronology and registration path
- Machine-detected amendment and tracked-term change view
- Official-source index for project-file archiving and downloadable CSV export
Secure checkout by PayPal.
AUTOMATED EVIDENCE SNAPSHOT
Unlock download · US$29Save this source-linked record
Download a printable HTML snapshot of the current public-record timeline and change view. A one-time download unlocks a saveable issuer record. Official sources remain controlling.
OFFICIAL SEC SUBMISSIONS
Open Evidence Snapshot →Captured filing chronology
- F-1/ARegistration & offeringOpen SEC filing →
- F-1/ARegistration & offeringOpen SEC filing →
- F-1/ARegistration & offeringOpen SEC filing →
- F-1/ARegistration & offeringOpen SEC filing →
- F-1/ARegistration & offeringOpen SEC filing →
- F-1/ARegistration & offeringOpen SEC filing →
- F-1Registration & offeringOpen SEC filing →
Only official SEC submission-index facts are automated here. The brief does not determine shell status, beneficial ownership, capitalization, legal compliance, valuation, active-trading status or transaction suitability. Those questions require the appropriate source documents and independently retained professionals.